Free tool
FAERS Monitor: Children'S Zyrtec Allergy
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021621 or its brand name (Children'S Zyrtec Allergy, Cetirizine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
125,869
Serious
60,579
48% of reports
Hospitalization
25,269
Death reported
7,591
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective18,075
- fatigue14,947
- pain12,772
- off label use11,291
- headache10,290
- rash10,192
- pruritus9,539
- nausea9,229
- alopecia8,700
- abdominal discomfort8,632
- dyspnoea7,961
- rheumatoid arthritis7,897
- hypersensitivity7,835
- arthralgia7,806
- diarrhoea7,490
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,241 |
| 2005 | 1,289 |
| 2006 | 1,241 |
| 2007 | 1,193 |
| 2008 | 1,333 |
| 2009 | 1,392 |
| 2010 | 1,867 |
| 2011 | 1,929 |
| 2012 | 2,524 |
| 2013 | 2,497 |
| 2014 | 3,141 |
| 2015 | 7,785 |
| 2016 | 8,477 |
| 2017 | 7,306 |
| 2018 | 7,362 |
| 2019 | 7,799 |
| 2020 | 8,608 |
| 2021 | 9,966 |
| 2022 | 10,533 |
| 2023 | 9,540 |
| 2024 | 10,389 |
| 2025 | 10,425 |
| 2026 | 8,025 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,928,290 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| rheumatoid arthritisSignal | 7,897 | 12.4 | 12.1 | 77,544 |
| abdominal discomfortSignal | 8,632 | 9.0 | 8.8 | 58,773 |
| alopeciaSignal | 8,700 | 7.7 | 7.5 | 48,919 |
| hypersensitivitySignal | 7,835 | 7.3 | 7.2 | 41,305 |
| pruritusSignal | 9,539 | 4.2 | 4.1 | 23,347 |
| rashSignal | 10,192 | 4.0 | 3.9 | 22,645 |
| painSignal | 12,772 | 3.5 | 3.5 | 23,321 |
| fatigueSignal | 14,947 | 3.3 | 3.2 | 23,729 |
| arthralgiaSignal | 7,806 | 3.2 | 3.1 | 11,662 |
| headacheSignal | 10,290 | 2.8 | 2.7 | 11,812 |
| dyspnoeaSignal | 7,961 | 2.4 | 2.3 | 6,381 |
| drug ineffectiveSignal | 18,075 | 2.3 | 2.3 | 14,123 |
| off label useSignal | 11,291 | 2.2 | 2.1 | 7,333 |
| nausea | 9,229 | 2.0 | 1.9 | 4,454 |
| diarrhoea | 7,490 | 1.9 | 1.9 | 3,534 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.